# Nested ecosystems theory for conceptualizing brain tumors

**Authors:** Lori A. Forster, David H. Gutmann

PMC · DOI: 10.1242/dmm.052763 · Disease Models & Mechanisms · 2026-02-27

## TL;DR

This paper introduces a new model of brain tumors as nested ecosystems to better understand their development and treatment.

## Contribution

The novelty is applying nested ecosystems theory to gliomas for understanding risk factors and treatment strategies.

## Key findings

- Brain tumors operate as ecosystems with interactions across four strata: intracellular, extracellular, intracorporeal, and extracorporeal.
- These interactions create biological heterogeneity and unique growth dependencies in gliomas.
- The model provides a framework for understanding how risk factors influence brain tumor biology and for developing new treatments.

## Abstract

The application of advanced multi-omic methodologies to studying brain tumors has culminated in the appreciation that these cancers function as ecosystems that depend on the interactions of a diverse collection of cell types and signals. This connectivity operates not only at the level of the cancer cell, in which variants create new growth dependencies, but also between tumor cells and the immediate tumor microenvironment, between tumor cells and cell populations residing elsewhere in the brain tissue or body, and in response to extracorporeal factors. The cellular and molecular relationships within these four interrelated strata (intracellular, extracellular, intracorporeal and extracorporeal) act in concert to dictate brain tumor development, progression, and therapeutic response by creating biological heterogeneity and unique growth dependencies. In this Perspective, we apply the concept of nested ecosystems to the most common brain tumor (glioma), providing a contextual framework to define how risk factors modify central nervous system oncobiology and to identify future targeted approaches to disease mitigation.

Summary: We propose a model of interactive and nested ecosystems to conceptualize how risk factors modify brain tumor pathogenesis, as well as a framework to discover alternative approaches to disease mitigation.

## Linked entities

- **Diseases:** glioma (MONDO:0021042)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, KIAA1549 (KIAA1549) [NCBI Gene 57670] {aka RP86}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, FGFR1 (fibroblast growth factor receptor 1) [NCBI Gene 2260] {aka BFGFR, CD331, CEK, ECCL, FGFBR, FGFR-1}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, QKI (QKI, KH domain containing RNA binding) [NCBI Gene 9444] {aka Hqk, QK, QK1, QK3, hqkI}, NF1 (neurofibromin 1) [NCBI Gene 4763] {aka NFNS, VRNF, WSS}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Il7 (interleukin 7) [NCBI Gene 16196] {aka A630026I06Rik, Il-7, hlb368}, PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156] {aka CD140A, PDGFR-2, PDGFR2}, TSC1 (TSC complex subunit 1) [NCBI Gene 7248] {aka LAM, TSC}, IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, OLIG2 (oligodendrocyte transcription factor 2) [NCBI Gene 10215] {aka BHLHB1, OLIGO2, PRKCBP2, RACK17, bHLHe19}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780] {aka DHS, ER, FAM38A, LMPH3, LMPHM6, Mib}, RORC (RAR related orphan receptor C) [NCBI Gene 6097] {aka IMD42, NR1F3, RORG, RZR-GAMMA, RZRG, TOR}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, NTRK2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 4915] {aka DEE58, EIEE58, GP145-TrkB, OBHD, TRKB, trk-B}
- **Diseases:** infections (MESH:D007239), brain disease (MESH:D001927), TAMs (MESH:D000072716), multiple sclerosis (MESH:D009103), brain cancer (MESH:D001932), cognitive problems (MESH:D003072), glioblastoma (MESH:D005909), allergic encephalomyelitis (MESH:D004681), neuronal injury (MESH:D009410), bacterial infections (MESH:D001424), allergic (MESH:D004342), Li-Fraumeni syndrome (MESH:D016864), dysbiosis (MESH:D064806), cancerous (MESH:D009369), Alzheimer's disease (MESH:D000544), fibrosarcoma (MESH:D005354), lung cancer (MESH:D008175), asthma (MESH:D001249), anxiety (MESH:D001007), traumatic brain injury (MESH:D000070642), Gliomas (MESH:D005910), airway inflammation (MESH:D007249), optic glioma (MESH:D020339), inherited cancer syndrome (MESH:D009386), neurofibromatosis type 1 (MESH:D009456), Neurological Disorders and Stroke (MESH:D009461), seizures (MESH:D012640), Hypoxia (MESH:D000860), obesity (MESH:D009765), nervous system tumors (MESH:D009423), tumorigenesis (MESH:D063646), atopy (MESH:C564133)
- **Chemicals:** temozolomide (MESH:D000077204), Ca2+ (-), lipid (MESH:D008055), sugar (MESH:D000073893), salt (MESH:D012492), glutamate (MESH:D018698)
- **Species:** Bacteroides (genus) [taxon 816], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Human alphaherpesvirus 3 (Varicella-zoster virus, no rank) [taxon 10335]
- **Mutations:** K27M

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12969768/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12969768/full.md

## References

121 references — full list in the complete paper: https://tomesphere.com/paper/PMC12969768/full.md

---
Source: https://tomesphere.com/paper/PMC12969768